Numa Masayuki

Title: The Innovative Contributions of Numa Masayuki in Cancer and Alzheimer's Disease Detection

Introduction

Numa Masayuki is a distinguished inventor based in Hino, Japan, known for his innovative research in biochemistry. With a focus on identifying substances that can aid in the diagnosis of critical medical conditions, Masayuki has made significant contributions to the field of health care.

Latest Patents

Masayuki holds one notable patent titled "Acta and Methods for Detecting the Same." This patent details an isolated and purified substance known as Acta, which possesses several unique characteristics. Acta has a molecular weight ranging from 60 kd to 70 kd as demonstrated in SDS-PAGE using a 12.5% gel. Importantly, it exhibits a reaction with a monoclonal antibody secreted by hybridoma FERM BP-3482. Additionally, Acta is remarkable for its ability to bind to chymotrypsin and DNA. This substance holds potential for diagnosing significant health conditions, specifically cancer and Alzheimer's disease.

Career Highlights

Numa Masayuki is affiliated with Konica Corporation, a company recognized for its contributions to imaging products and solutions. Throughout his career, Masayuki has leveraged his expertise to innovate and push the boundaries of medical diagnostics, focusing on creating effective solutions for critical diseases.

Collaborations

In his professional endeavors, Numa Masayuki collaborates closely with his coworker, Masahiko Yamasaki. Their partnership combines knowledge and skills, enhancing their research initiatives and fostering innovative breakthroughs in their field.

Conclusion

Numa Masayuki stands out as a vital contributor to medical innovation, particularly in the realm of disease detection. His patent for Acta represents a significant step forward in diagnosing conditions like cancer and Alzheimer's disease. Through his work at Konica Corporation and ongoing collaborations, Masayuki continues to impact the health care sector with groundbreaking solutions.